Latest news
Malaria shaped distribution of early human populations
Scientists investigated whether Plasmodium falciparum induced malaria shaped human habitat choice between 74,000 and 5,000 years ago, finding that malaria influenced habitat choice by pushing human groups away from high-risk environments and separating populations across the landscape.
COVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
High levels of gut bacterial toxin trigger lupus nephritis
Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.
Secret to a healthy liver found in a young microbiome
Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study.
Scientists find a new way coronaviruses can get into human cells
An international team of researchers has identified an East African bat coronavirus capable of entering human cells. Whilst the virus can bind to a cell receptor found in the human lung, preliminary testing in Kenya suggests it has not spilled over into the local human population.
Researchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
Malaria shaped distribution of early human populations
Scientists investigated whether Plasmodium falciparum induced malaria shaped human habitat choice between 74,000 and 5,000 years ago, finding that malaria influenced habitat choice by pushing human groups away from high-risk environments and separating populations across the landscape.
COVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
High levels of gut bacterial toxin trigger lupus nephritis
Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
Researchers fight oral cancer with bioengineered chewing gum
Research shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
Metagenomic software advance boosts research into microbial diversity
Researchers studying the diversity of microbes in environmental samples now have access to a new tool that opens the door to cheaper, more accessible analysis of their samples.
Researchers combine polarized light and a magnetic field to spot malaria under the microscope
Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative measurements that could enable faster and more objective detection of malaria in blood.
WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
Flu vaccine no longer required for U.S. military
The U.S. military is ending its long-standing requirement that service members receive the annual flu shot, a decision announced by Defense Secretary Pete Hegseth.
Pioneering virologist Bernard Roizman dies at 96
Bernard Roizman, ScD, world-leading expert on herpes simplex virus (HSV) and Joseph Regenstein Distinguished Service Professor Emeritus of Microbiology and Molecular Genetics and Cell Biology at The University of Chicago, died on April 13, 2026, at the age of 96.